Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Artemis International Solutions Corporation was a prominent global provider of project and resource management software, widely recognized for its flagship "Artemis" suite of tools. While not a biotechnology company itself, it was a critical vendor to the life sciences industry, where its software was the standard for managing complex drug development pipelines and optimizing R&D investments. The company helped large pharmaceutical organizations coordinate multi-year clinical trials and resource allocation across global portfolios. Artemis was publicly traded on NASDAQ under the symbol AMSI until its acquisition by Versata Enterprises in 2006.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Artemis International Solutions.